TrialInternational journal of clinical oncology2021

A phase II study of FOLFOXIRI plus bevacizumab as initial chemotherapy for patients with untreated metastatic colorectal cancer: TRICC1414 (BeTRI).

Katsunori Shinozaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.